Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rifinah 300mg/150mg tablets
0501090S0BBABAB
|
Rifinah | Rifampicin combined preparations | Infections | 145 |
|
Rifampicin 300mg / Isoniazid 150mg tablets
0501090S0AAABAB
|
Rifampicin/isoniazid | Rifampicin combined preparations | Infections | 114 |
|
Rifinah 150mg/100mg tablets
0501090S0BBAAAA
|
Rifinah | Rifampicin combined preparations | Infections | 37 |
|
Rifater tablets
0501090S0BDAAAC
|
Rifater | Rifampicin combined preparations | Infections | 22 |
|
Voractiv tablets
0501090S0BEAAA0
|
Voractiv | Rifampicin combined preparations | Infections | 20 |
|
Rifampicin 150mg / Isoniazid 100mg tablets
0501090S0AAAAAA
|
Rifampicin/isoniazid | Rifampicin combined preparations | Infections | 2 |
|
Generic Rifater tablets
0501090S0AAACAC
|
Rifampicin/isoniazid | Rifampicin combined preparations | Infections | No data available |
|
Rifampicin 300mg / Isoniazid 150mg capsules
0501090S0AAADAD
|
Rifampicin/isoniazid | Rifampicin combined preparations | Infections | No data available |
|
Rifater tablets (Imported)
0501090S0BDABAC
|
Rifater | Rifampicin combined preparations | Infections | No data available |
|
Rimactazid 150 tablets
0501090S0BCAAAA
|
Rimactazid | Rifampicin combined preparations | Infections | No data available |
|
Rimactazid 300 tablets
0501090S0BCABAB
|
Rimactazid | Rifampicin combined preparations | Infections | No data available |
|
Rimstar tablets
0501090S0BGAAA0
|
Rimstar | Rifampicin combined preparations | Infections | No data available |
|
Sinerdol Iso 300mg/150mg capsules
0501090S0BFAAAD
|
Sinerdol | Rifampicin combined preparations | Infections | No data available |
|
Voractiv (Imported)
0501090S0BEABA0
|
Voractiv | Rifampicin combined preparations | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.